Aster DM Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

1,197.21

1,077.87

1,000.34

1,049.81

1,086.44

1,001.87

973.59

Other Operating Income

0.00

Total Operating income

1,197.21

1,077.87

1,000.34

1,049.81

1,086.44

1,001.87

973.59

Raw Material Cost

0.00

Purchase of Finished goods

271.05

247.15

218.17

232.04

244.66

225.29

230.01

(Increase) / Decrease In Stocks

-0.04

-0.01

7.06

14.97

-7.18

3.32

1.79

Employee Cost

211.92

194.81

182.96

193.64

193.35

190.44

170.89

Power Cost

0.00

Manufacturing Expenses

6.13

7.76

6.99

7.65

8.97

5.60

6.20

Selling and Distribution Expenses

257.15

239.70

229.98

229.39

235.89

225.91

220.10

Other Expenses

201.16

181.10

163.11

182.94

191.01

187.77

185.26

Total Expenditure (Excl Depreciation)

947.37

870.51

808.27

860.63

866.70

838.33

814.25

Operating Profit (PBDIT) excl Other Income

249.84

207.36

192.07

189.18

219.74

163.54

159.34

Other Income

28.25

33.18

31.28

32.99

35.24

48.72

4.08

Operating Profit (PBDIT)

278.09

240.54

223.35

222.17

254.98

212.26

163.42

Interest

30.76

30.77

32.43

30.77

31.46

29.15

29.88

Exceptional Items

-0.36

-4.39

-26.42

-23.72

0.00

5,071.20

-43.91

Gross Profit (PBDT)

246.97

205.38

164.50

167.68

223.52

183.11

133.54

Depreciation

66.12

63.22

63.95

62.21

62.27

60.41

58.36

Profit Before Tax

166.85

136.44

90.54

101.88

158.65

119.99

72.32

Tax

45.54

42.88

5.00

37.49

52.89

38.99

30.57

Provisions and contingencies

0.00

Profit After Tax

135.31

99.28

95.55

67.98

108.36

83.71

44.61

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

5,071.20

-43.91

Net Profit

135.31

99.28

95.55

67.98

108.36

5,154.91

0.70

Share in Profit of Associates

-14.00

-5.72

-10.01

-3.59

-2.60

-2.71

-2.86

Minority Interest

11.31

8.04

6.52

7.60

8.92

7.02

21.87

Other related items

0.00

Consolidated Net Profit

110.00

85.52

79.02

56.79

96.84

5,145.18

-24.03

Equity Capital

518.13

499.52

Face Value

10.0

Reserves

0.00

Earnings per share (EPS)

2.12

1.65

1.58

1.14

1.94

103.0

-0.48

Diluted Earnings per share

2.13

1.67

1.58

1.14

1.94

103.19

-0.48

Operating Profit Margin (Excl OI)

20.87%

19.24%

19.2%

18.02%

20.23%

16.32%

16.37%

Gross Profit Margin

20.63%

19.05%

16.44%

15.97%

20.57%

18.28%

13.72%

PAT Margin

10.13%

8.68%

8.55%

6.13%

9.73%

8.08%

4.29%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 10.20% vs 16.89% in Sep 2024

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 13.59% vs 414.52% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 13.70% vs 51.54% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is -2.23% vs 4.21% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Aster DM Health. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

1,197.21

1,643.79

-446.58

-27.17%

Other Operating Income

0.00

Total Operating income

1,197.21

1,643.79

-446.58

-27.17%

Raw Material Cost

0.00

322.96

-322.96

-100.00%

Purchase of Finished goods

271.05

0.00

271.05

(Increase) / Decrease In Stocks

-0.04

-0.74

0.70

94.59%

Employee Cost

211.92

299.09

-87.17

-29.15%

Power Cost

0.00

Manufacturing Expenses

6.13

254.87

-248.74

-97.59%

Selling and Distribution Expenses

257.15

0.00

257.15

Other Expenses

201.16

365.11

-163.95

-44.90%

Total Expenditure (Excl Depreciation)

947.37

1,241.29

-293.92

-23.68%

Operating Profit (PBDIT) excl Other Income

249.84

402.50

-152.66

-37.93%

Other Income

28.25

23.99

4.26

17.76%

Operating Profit (PBDIT)

278.09

426.49

-148.40

-34.80%

Interest

30.76

42.26

-11.50

-27.21%

Exceptional Items

-0.36

0.21

-0.57

-271.43%

Gross Profit (PBDT)

246.97

384.23

-137.26

-35.72%

Depreciation

66.12

87.48

-21.36

-24.42%

Profit Before Tax

166.85

295.48

-128.63

-43.53%

Tax

45.54

37.19

8.35

22.45%

Provisions and contingencies

0.00

Profit After Tax

135.31

259.57

-124.26

-47.87%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

0.21

-0.21

-100.00%

Net Profit

135.31

259.78

-124.47

-47.91%

Share in Profit of Associates

-14.00

-1.28

-12.72

-993.75%

Minority Interest

11.31

0.12

11.19

9,325.00%

Other related items

0.00

Consolidated Net Profit

110.00

258.37

-148.37

-57.43%

Equity Capital

518.13

204.36

313.77

153.54%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

2.12

12.64

-10.52

-83.23%

Diluted Earnings per share

2.13

12.72

-10.59

-83.25%

Operating Profit Margin (Excl OI)

20.87%

24.49%

0.00

-3.62%

Gross Profit Margin

20.63%

23.37%

0.00

-2.74%

PAT Margin

10.13%

15.71%

0.00

-5.58%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 1,197.21 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 11.07% vs 7.75% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 10.20% vs 16.89% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 110.00 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 28.62% vs 8.23% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 13.59% vs 414.52% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 249.84 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 20.49% vs 7.96% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 13.70% vs 51.54% in Sep 2024

Quarterly - Interest

Interest 30.76 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -0.03% vs -5.12% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -2.23% vs 4.21% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.87%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024